D Neil Granger Selected Research

sodium sulfate (sodium bisulfate)

3/2016	IL-6 Mediates the Intestinal Microvascular Thrombosis Associated with Experimental Colitis.
2/2014	Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6.
7/2013	Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.
5/2013	Platelet abnormalities during colonic inflammation.
11/2011	Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation.
12/2010	Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis.
2/2009	Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis.
11/2008	Thrombin mediates the extraintestinal thrombosis associated with experimental colitis.
9/2008	Role of the protein C pathway in the extraintestinal thrombosis associated with murine colitis.
11/2007	Mechanisms of platelet and leukocyte recruitment in experimental colitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Neil Granger Research Topics

Disease

31	Inflammation (Inflammations) 01/2021 - 10/2002
23	Thrombosis (Thrombus) 01/2019 - 07/2007
18	Hypercholesterolemia 05/2016 - 10/2002
16	Colitis 03/2016 - 12/2002
16	Ischemia 09/2015 - 04/2002
13	Stroke (Strokes) 01/2019 - 05/2004
13	Ischemic Stroke 01/2019 - 04/2005
9	Hypertension (High Blood Pressure) 01/2019 - 11/2010
9	Brain Ischemia (Cerebral Ischemia) 05/2016 - 06/2004
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 12/2004
7	Infarction (Infarctions) 05/2016 - 12/2004
6	Sepsis (Septicemia) 03/2009 - 03/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2007
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2013 - 04/2004
5	Brain Injuries (Brain Injury) 11/2011 - 06/2004
4	Reperfusion Injury 05/2016 - 05/2004
4	Brain Edema (Cerebral Edema) 07/2011 - 08/2004
4	Obesity 03/2009 - 03/2005
4	Sickle Cell Anemia (Hemoglobin S Disease) 09/2007 - 06/2004
3	Transient Ischemic Attack 09/2015 - 04/2005
3	Brain Infarction 11/2014 - 04/2005
3	Atherosclerosis 02/2010 - 02/2005
2	Intracranial Thrombosis (Cerebral Thrombosis) 01/2019 - 09/2015
2	Hemorrhage 12/2017 - 10/2004
2	Neointima 01/2014 - 01/2011
2	Thrombocytosis (Thrombocythemia) 07/2013 - 05/2013
2	Infections 04/2013 - 12/2002
2	Intracranial Sinus Thrombosis (Sinus Thrombosis) 03/2010 - 01/2010
2	Edema (Dropsy) 01/2010 - 09/2008
2	Pre-Eclampsia (Preeclampsia) 01/2010 - 02/2002
2	Neutropenia 11/2007 - 06/2004
2	Malaria 05/2003 - 04/2003
1	Thromboinflammation 01/2019

Drug/Important Bio-Agent (IBA)

17	P-SelectinIBA 07/2011 - 12/2002
16	Coloring Agents (Dyes)IBA 01/2019 - 07/2007
15	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2016 - 12/2002
15	Dextrans (Dextran)FDA Link 03/2016 - 12/2002
13	CytokinesIBA 05/2016 - 12/2002
12	Angiotensin IIIBA 01/2019 - 02/2005
8	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2008
8	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2015 - 03/2002
8	Superoxides (Superoxide)IBA 02/2012 - 10/2002
8	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2011 - 02/2004
7	Thrombin FDA Link 01/2019 - 07/2007
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
6	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 04/2003
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 10/2002
5	Protein CIBA 07/2014 - 09/2008
5	CD40 Ligand (CD40L)IBA 01/2013 - 04/2005
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2011 - 09/2002
4	Thromboplastin (Tissue Factor)IBA 07/2016 - 07/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015 - 04/2002
4	salicylhydroxamic acid (SHAM)IBA 11/2014 - 06/2006
4	Endothelial Protein C ReceptorIBA 07/2014 - 09/2008
4	Heparin (Liquaemin)FDA LinkGeneric 07/2014 - 11/2008
4	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 11/2011 - 06/2004
4	LigandsIBA 11/2007 - 05/2003
4	Monoclonal AntibodiesIBA 04/2007 - 12/2002
3	Annexin A1IBA 01/2021 - 05/2016
3	IntegrinsIBA 01/2019 - 12/2002
3	Pharmaceutical PreparationsIBA 01/2019 - 05/2003
3	Peptides (Polypeptides)IBA 05/2016 - 06/2007
3	Oxygen (Dioxygen)IBA 12/2015 - 09/2007
3	Chemokine CCL5IBA 04/2011 - 09/2008
3	Interleukin-12 (IL 12)IBA 09/2008 - 12/2003
3	Peroxidase (Myeloperoxidase)IBA 07/2004 - 04/2002
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 05/2016
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019 - 09/2015
2	AntibodiesIBA 01/2019 - 03/2010
2	Oxidants (Oxidizing Agents)IBA 01/2017 - 02/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2016 - 12/2007
2	InterleukinsIBA 09/2015 - 12/2010
2	Antithrombin IIIIBA 07/2014 - 11/2008
2	HirudinsIBA 07/2014 - 11/2008
2	InterferonsIBA 04/2013 - 11/2008
2	NitrogenIBA 02/2012 - 09/2007
2	Type 1 Angiotensin ReceptorIBA 11/2011 - 06/2004
2	EnzymesIBA 07/2011 - 06/2006
2	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2011 - 08/2010
2	CollagenIBA 07/2011 - 12/2002
2	E-SelectinIBA 03/2011 - 12/2002
2	BradykininIBA 12/2010 - 12/2005
2	Messenger RNA (mRNA)IBA 08/2010 - 06/2004
2	LipidsIBA 02/2009 - 02/2005
2	AntithrombinsIBA 11/2008 - 07/2007
2	Interleukin-10 (Interleukin 10)IBA 09/2008 - 01/2005
2	LeptinIBA 03/2008 - 06/2007
2	Dextran SulfateIBA 07/2004 - 04/2004
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2002 - 03/2002
2	Ethanol (Ethyl Alcohol)IBA 09/2002 - 04/2002
1	PhosphatidylserinesIBA 01/2019
1	Collagen ReceptorsIBA 01/2019
1	CalciumIBA 01/2019
1	Thromboxane B2IBA 01/2019
1	acetyl- prolyl- histidyl- seryl- cysteinyl- asparaginamideIBA 01/2018
1	FibrinIBA 12/2017
1	Neuroprotective AgentsIBA 12/2017

Therapy/Procedure

12	Therapeutics 12/2017 - 05/2004
5	Ligation 01/2011 - 03/2005
2	Punctures 01/2008 - 03/2006